Selkirk Pharma

Executive Summary

Selkirk Pharma is a US-based contract manufacturing organization (CMO) focused on sterile fill/finish services for injectable drug products, serving both clinical and commercial stages. Founded in 2019 and headquartered in Spokane, Washington, the company differentiates itself through onshore capacity, rapid turnaround via its ClinFAST™ program, and a high-yield automated facility. As a private company, Selkirk Pharma benefits from growing demand for domestic aseptic manufacturing, driven by supply chain resilience trends and drug shortages. The company's targeted expansion and niche specialization position it for steady growth, though its limited track record and competitive landscape warrant a moderate conviction.

Upcoming Catalysts (preview)

• 2026Facility expansion or capacity addition announced40% success
• TBDMajor client contract win (e.g., top-20 pharma)30% success
• H2 2026Regulatory inspection outcome (FDA) for new or expanded lines60% success